SHANGHAI JUNSHI BIO YC1 Financial Flexibility Index
SHANGHAI JUNSHI BIO YC1 financial flexibility index. SHANGHAI JUNSHI BIO YC1 (8SJ) has a Financial Flexibility Index of 0.04x as of December 2025. Free cash flow of €253.78 Million (operating CF €-514.51 Million minus capex €768.30 Million) represents 0% of total liabilities (€6.33 Billion).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SHANGHAI JUNSHI BIO YC1 (2021–2025)
Financial flexibility index of SHANGHAI JUNSHI BIO YC1 from 2021 to 2025. Historical Financial Flexibility Index trend for SHANGHAI JUNSHI BIO YC1 across 5 annual periods. Explore cash flow to debt ratio of SHANGHAI JUNSHI BIO YC1 to assess how comfortably operating cash covers total debt obligations.
SHANGHAI JUNSHI BIO YC1 Financial Flexibility Index by Year (2021–2025)
SHANGHAI JUNSHI BIO YC1 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for SHANGHAI JUNSHI BIO YC1. For the full cash flow conversion analysis, see cash efficiency ratio of SHANGHAI JUNSHI BIO YC1.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | €253.78 Million | €-514.51 Million | €6.33 Billion | ▲ +125.9% |
| 2024 | -0.16x | €-751.85 Million | €-1.44 Billion | €4.85 Billion | ▲ +47.3% |
| 2023 | -0.29x | €-1.18 Billion | €-2.01 Billion | €4.02 Billion | ▲ +40.8% |
| 2022 | -0.50x | €-1.38 Billion | €-1.78 Billion | €2.78 Billion | ▼ -652.5% |
| 2021 | 0.09x | €244.33 Million | €-641.90 Million | €2.72 Billion | — |